Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Virome01:26

Human Virome

42
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
42
Vaccines01:21

Vaccines

57
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
57
Vaccine Production01:23

Vaccine Production

94
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
94
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miRNAs from Inflamed Gingiva Link Gene Signaling to Increased MET Expression.

Journal of dental research·2023
Same author

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.

The Lancet. Infectious diseases·2022
Same author

BACH1 Binding Links the Genetic Risk for Severe Periodontitis with <i>ST8SIA1</i>.

Journal of dental research·2021
Same author

<i>Entamoeba gingivalis</i> Exerts Severe Pathogenic Effects on the Oral Mucosa.

Journal of dental research·2021
Same author

History of BCG Vaccination Recommendations in East and West Germany from 1951 to Date.

Pneumologie (Stuttgart, Germany)·2020
Same author

[DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)].

Pneumologie (Stuttgart, Germany)·2020

Related Experiment Video

Updated: Apr 15, 2026

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

9.3K

Molecular signatures for vaccine development.

J Maertzdorf1, S H E Kaufmann1, J Weiner1

  • 1Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.

Vaccine
|April 11, 2015
PubMed
Summary

Understanding vaccine-induced immune responses is key for developing new vaccines. High-throughput profiling reveals early interferon signatures and distinct transcriptional profiles for different vaccine types, guiding adaptive immunity.

Keywords:
Defense responseSignaturesVaccination

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Related Experiment Videos

Last Updated: Apr 15, 2026

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

9.3K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • The immune system employs specialized mechanisms to defend against pathogens.
  • Developing effective vaccines requires a deep understanding of these immune responses.
  • Vaccinology increasingly utilizes high-throughput profiling for detailed insights.

Purpose of the Study:

  • To elucidate the molecular mechanisms of immune responses to vaccines.
  • To understand how different vaccine formulations elicit distinct immune signatures.
  • To explore the role of early innate immune responses in shaping adaptive immunity.

Main Methods:

  • Transcriptional profiling of immune responses.
  • Analysis of high-throughput data from vaccine and infection studies.
  • Focus on early molecular signatures.

Main Results:

  • Nearly all vaccines induce an early interferon-dominated transcriptional signature.
  • Distinct vaccine formulations elicit unique transcriptional profiles.
  • Early innate immune responses are critical for subsequent adaptive immunity.

Conclusions:

  • Transcriptional profiling provides a comprehensive view of immunological responses.
  • Early molecular signatures are crucial for understanding vaccine efficacy.
  • The study highlights the importance of early innate immunity in vaccine development.